Galmed Pharmaceuticals (GLMD) Stock: Buy, Sell, or Hold?
$4.63
+0.80 (+21.05%)
▲
5d:
+17.96%
30d:
+680.64%
90d:
+787.31%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
37/100
Position
FAIR
Forward P/E & Valuation
-0.6x
Next 12M consensus est.
Wall Street Target
$12.00
+159.2% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$3.74 / $4.63
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
ℹ️ NEUTRAL: GLMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GLMD is currently trading at $4.63, which is considered fair based on recent price action.
Technical Outlook: Technically, GLMD is in a strong uptrend. The price is approaching resistance at $4.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 21.0% recently.
Market Sentiment: GLMD scores 16/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+159.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLMD is in a strong uptrend. The price is approaching resistance at $4.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 21.0% recently.
Market Sentiment: GLMD scores 16/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+159.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
37/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
50.0%
Trading Range & Key Levels
Support Level
$3.74
Resistance Level
$4.63
Current Trend
Strong Uptrend
Technical data as of
Sep 9, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (16/100)
- BULLISH: Strong upward momentum (+21.0%)
- BULLISH: Trading 159.2% below Wall St target ($12.00)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.64
Wall Street Target
$12.00
(+159.2%)
Share GLMD Analysis
Share this live GLMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GLMD)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 18, 2026
Daily AI digest
AI Retail Discussion Summary:
Galmed Pharmaceuticals announced significant pre-clinical results of a combination of Aramchol and Xtandi® for prostate cancer, demonstrating a 3-4 fold increase in cell death compared to Xtandi alone.
Key Retail Themes:
pre-clinical study results
combination therapy for prostate cancer
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 11:47 PM ET
Data refreshes hourly during market hours. Next update: 12:47 AM
Data refreshes hourly during market hours. Next update: 12:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 65 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 58 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GLMD Research Pages
